Four series of reports on visit to Australia by China Association for the promotion of drugs

Source: on Thursday, February 13, 2014, China Association for the promotion of drugs (CFDA), led by executive chairman song Ruilin, went to the Ministry of health of the federal government of Australia for investigation Megan Keaney, head of MBS paste of the Ministry of health, and felicity McNeill of PBS communicated with the investigation team The two officials introduced the situation and trend of health expenditure of Australian federal government in recent years, and the main factors influencing the government's health expenditure The federal government's health expenditure consists of three parts: first, the subsidy scheme (MBS) for medical services ）It is mainly to subsidize the medical institutions' TCM students in providing diagnosis and treatment services, and the inpatients; secondly, it is to subsidize the medical expenses of outpatients in the community; thirdly, it is to subsidize the operation of public hospitals, including the head expenses, equipment purchase expenses, etc The government reduces the cost of drugs by encouraging the use of generic drugs, pharmacists' income reporting and other systems They also introduced the drug price control methods in the drug subsidy plan The inspection team also introduced the Chinese medical insurance system, prevention of unreasonable use of drugs, medical cost control and other related systems to the two officials, and believed that the Australian medical cost control concept and related systems are worth learning and learning from the Chinese government President Song Ruilin said: Thank you very much for the introduction of the two officials, and invite them to visit China at a suitable time to exchange detailed medical and health policies of Australia The two officials readily accepted the invitation Communication between the team and officials of the federal government's Ministry of health